BR112023017675A2 - Alimento canino oral e métodos para controlar infestações de carrapatos em um canino - Google Patents
Alimento canino oral e métodos para controlar infestações de carrapatos em um caninoInfo
- Publication number
- BR112023017675A2 BR112023017675A2 BR112023017675A BR112023017675A BR112023017675A2 BR 112023017675 A2 BR112023017675 A2 BR 112023017675A2 BR 112023017675 A BR112023017675 A BR 112023017675A BR 112023017675 A BR112023017675 A BR 112023017675A BR 112023017675 A2 BR112023017675 A2 BR 112023017675A2
- Authority
- BR
- Brazil
- Prior art keywords
- canine
- methods
- oral
- controlling
- dog food
- Prior art date
Links
- 201000001064 tick infestation Diseases 0.000 title abstract 2
- 241000282465 Canis Species 0.000 abstract 6
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 abstract 2
- 241000238876 Acari Species 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P7/00—Arthropodicides
- A01P7/04—Insecticides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
- A01N43/76—1,3-Oxazoles; Hydrogenated 1,3-oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P17/00—Pest repellants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Insects & Arthropods (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163159760P | 2021-03-11 | 2021-03-11 | |
| PCT/US2022/019889 WO2022192631A1 (en) | 2021-03-11 | 2022-03-11 | Oral canine feed and methods for controlling tick infestations in a canine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023017675A2 true BR112023017675A2 (pt) | 2023-11-14 |
Family
ID=83227132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023017675A BR112023017675A2 (pt) | 2021-03-11 | 2022-03-11 | Alimento canino oral e métodos para controlar infestações de carrapatos em um canino |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230413822A1 (https=) |
| EP (1) | EP4304357A4 (https=) |
| JP (1) | JP2024511956A (https=) |
| KR (1) | KR20230162001A (https=) |
| CN (1) | CN117320554A (https=) |
| AU (1) | AU2022232440A1 (https=) |
| BR (1) | BR112023017675A2 (https=) |
| CA (1) | CA3211576A1 (https=) |
| MX (1) | MX2023010378A (https=) |
| WO (1) | WO2022192631A1 (https=) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY148805A (en) * | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
| DE602004017347D1 (de) * | 2003-11-04 | 2008-12-04 | Intervet Int Bv | Azol-pestiziden |
| TWI556741B (zh) * | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | 異唑啉組成物及其作為抗寄生蟲藥上的應用 |
| WO2012155352A1 (en) * | 2011-05-19 | 2012-11-22 | Eli Lilly And Company | Dihydroisoxazole compounds, parasiticidal uses and formulations thereof |
| AR088669A1 (es) * | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos |
| LT2811998T (lt) * | 2012-02-06 | 2019-02-25 | Merial, Inc. | Paraziticidinės peroralinės veterinarinės kompozicijos, apimančios sistemiškai veikiančius aktyviuosius agentus, būdai ir jų panaudojimas |
| EP2833866B2 (en) * | 2012-04-04 | 2024-11-27 | Intervet International B.V. | Soft chewable pharmaceutical products |
| RU2688919C1 (ru) * | 2013-12-20 | 2019-05-23 | Интервет Интернэшнл Б.В. | Изоксазолиновые композиции и их применение в провилактике или лечении паразитарных инвазий животных |
| HUE059228T2 (hu) * | 2015-06-23 | 2022-10-28 | Intervet Int Bv | E vitamint tartalmazó izoxazolin oldat, fertõtlenített ivóvízzel való felhasználásra |
| EP4487846A3 (en) * | 2018-09-05 | 2025-03-19 | Zoetis Services LLC | Palatable antiparasitic formulations |
| WO2020201440A1 (en) * | 2019-04-03 | 2020-10-08 | Virbac | Low dose fluralaner compositions for protection against parasitic invertebrate pest |
-
2022
- 2022-03-11 KR KR1020237034394A patent/KR20230162001A/ko active Pending
- 2022-03-11 CN CN202280020528.8A patent/CN117320554A/zh active Pending
- 2022-03-11 MX MX2023010378A patent/MX2023010378A/es unknown
- 2022-03-11 JP JP2023555750A patent/JP2024511956A/ja active Pending
- 2022-03-11 CA CA3211576A patent/CA3211576A1/en active Pending
- 2022-03-11 BR BR112023017675A patent/BR112023017675A2/pt unknown
- 2022-03-11 WO PCT/US2022/019889 patent/WO2022192631A1/en not_active Ceased
- 2022-03-11 EP EP22768056.8A patent/EP4304357A4/en active Pending
- 2022-03-11 AU AU2022232440A patent/AU2022232440A1/en active Pending
-
2023
- 2023-09-10 US US18/464,222 patent/US20230413822A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4304357A1 (en) | 2024-01-17 |
| US20230413822A1 (en) | 2023-12-28 |
| EP4304357A4 (en) | 2025-01-22 |
| CN117320554A (zh) | 2023-12-29 |
| KR20230162001A (ko) | 2023-11-28 |
| AU2022232440A1 (en) | 2023-09-21 |
| JP2024511956A (ja) | 2024-03-18 |
| CA3211576A1 (en) | 2022-09-15 |
| WO2022192631A1 (en) | 2022-09-15 |
| MX2023010378A (es) | 2024-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023001195A2 (pt) | Composto ou racemato, estereoisômero, tautômero, composto isotopicamente rotulado, solvato, polimorfo, sal farmaceuticamente aceitável ou composto pró-fármaco do mesmo, composto, método de preparação para composto ou racemato, estereoisômero, tautômero, composto isotopicamente rotulado, solvato, polimorfo, sal farmaceuticamente aceitável ou composto de pró-fármaco, composição farmacêutica, método para tratar uma doença associada com a ativação do caminho alternativo de complemento, e, uso do composto | |
| Ren et al. | Immunohistochemical evaluation of osteoclast recruitment during experimental tooth movement in young and adult rats | |
| MX2019007745A (es) | Nuevos derivados de fenilo. | |
| BR112018072064B8 (pt) | Uso de triglicerídeos de cadeia média para preparação de composições nutricionais para proteção cardíaca em animais de estimação | |
| BRPI0514253A (pt) | terapia de combinação para diabetes, obesidade e doenças cardiovasculares usando composições contendo inibidores de gdf-8 | |
| NO20081731L (no) | Trazodon-sammensetning for en gang om dagen administrering | |
| BR112022020814A2 (pt) | Métodos para tratamento de síndrome de liberação de citocina | |
| BR112022004036A2 (pt) | Comprimido mastigável palatável | |
| BR112018068784A2 (pt) | método para o tratamento de leucemia | |
| BR112021021015A2 (pt) | Mistura de nutrientes à base de triglicerídeos de cadeia média (tcm) para fornecer benefícios de saúde a animais | |
| BR112019005456A2 (pt) | composição farmacêutica e método para tratamento de esteatose hepática não alcoólica | |
| BR112022012258A2 (pt) | Sal cristalino de bromidreto de um inibidor de ezh2, sua preparação e composição farmacêutica útil para o tratamento de câncer | |
| MX2023000763A (es) | Anticuerpos anti-il-36r para el tratamiento de dermatosis neutrofilas. | |
| BR112023017675A2 (pt) | Alimento canino oral e métodos para controlar infestações de carrapatos em um canino | |
| BR112022003323A2 (pt) | Método terapêutico ou profilático para diabetes usando medicina de combinação | |
| BRPI0510370A (pt) | derivados de ácido fenoxi-alquil-carboxìlico no tratamento de doenças inflamatórias | |
| BR112021021774A2 (pt) | Blenda de nutrientes à base de mct para fornecer benefícios de saúde a animais | |
| BR112023017501A2 (pt) | Alimentação e métodos para o controle de infestações de carrapato em um mamífero | |
| BR112023017446A2 (pt) | Ração canina oral e métodos para controle de infestações de pulgas em um canino | |
| BR112022010229A2 (pt) | Método para melhora não terapêutica da trajetória de crescimento ou desenvolvimento corporal pós-natal em um lactente que nasce de uma mãe com sobrepeso ou obesa no momento da concepção do lactente e composição nutricional | |
| BR112021024835A2 (pt) | Tratamento para sinuclenopatias | |
| BR112022015046A2 (pt) | Uso de forsitina e/ou seus derivados, método para a inibição da proteína 3clpro do vírus covid-19, uso de composição de forsitina/forsitosídeo, métodos para uso contra o vírus covid-19 ou para o tratamento de doenças causadas pelo vírus covid-19, composição de forsitina/forsitosídeo e medicamento compreendendo uma composição de forsitina/forsitosídeo | |
| BR112022022220A2 (pt) | Composto, composição farmacêutica, uso do composto, e método para tratar, regular e/ou prevenir uma doença relacionada a uma proteína mutante de egfr | |
| BR112023020104A2 (pt) | Métodos para recuperação pós-operação, para facilitar a recuperação ou reduzir o tempo de recuperação da anestesia, para prevenir ou tratar distúrbios/depressão respiratória pós-operatória ou distúrbios/depressão respiratória induzida por opioides, sedação pós-operatória ou sedação induzida por opioides e para reduzir um efeito colateral de opioides | |
| CL2023002894A1 (es) | Combinación de un inhibidor de hdac6 y un inhibidor del punto de control de ctla4 |